Dechra Pharmaceuticals PLC
LSE:DPH
Dechra Pharmaceuticals PLC
LSE:DPH
Price:
3 866 GBX
Updated:
May 10, 2024
Dechra Pharmaceuticals PLC
Cash from Financing Activities
|
Dechra Pharmaceuticals PLC
Cash from Financing Activities Peer Comparison
Comparables:
GSK
AZN
VRNA
INDV
HIK
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Cash from Financing Activities
£316.5m
|
CAGR 3-Years
39%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Cash from Financing Activities
-£6.4B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
1%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Cash from Financing Activities
-$2.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
2%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Cash from Financing Activities
$92.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Cash from Financing Activities
-$62m
|
CAGR 3-Years
-78%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Cash from Financing Activities
-$337m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
See Also
What is Dechra Pharmaceuticals PLC's Cash from Financing Activities?
Cash from Financing Activities
316.5m
GBP
316.5m
GBP
Based on the financial report for Jun 30, 2023, Dechra Pharmaceuticals PLC's Cash from Financing Activities amounts to 316.5m GBP.
What is Dechra Pharmaceuticals PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
10%
10%
The average annual Cash from Financing Activities growth rates for Dechra Pharmaceuticals PLC have been 39% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
